Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
St George Mining hits record 178m high-grade intercept at Araxá, reinforcing global scale - 210 Moving Design Frill for Summer 2023
- 3She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life.
- 4Air India chief resigns 10 months after devastating Ahmedabad crash and amid mounting financial troubles
- 57 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!)
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- What loving-kindness meditation is and how to practice it in the new year
- Public mistrust linked to drop in deceased donor organ donations and kidney transplants
- The most effective method to Begin Your Excursion in Gold Venture
- FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
- Sheinelle Jones will cohost fourth hour of 'Today' with Jenna Bush Hager: Here's what to know about her
- Investigating the Advantages of a Bank account: A Complete Aide
- The most effective method to Make a Dazzling Site in 5 Basic Advances
- Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
